DAFNA Capital Management as of Dec. 31, 2012
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 47 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharmacyclics | 12.4 | $7.9M | 136k | 57.78 | |
| Ym Biosciences | 9.8 | $6.3M | 2.2M | 2.87 | |
| Novadaq Technologies | 9.0 | $5.7M | 641k | 8.88 | |
| Insulet | 5.5 | $3.5M | 165k | 21.22 | |
| ARIAD Pharmaceuticals | 5.2 | $3.3M | 172k | 19.18 | |
| Insulet Corp Note 3. 750% 6/1 4 | 5.1 | $3.2M | 3.0M | 1.08 | |
| Given Imaging Ltd ord shs m | 4.6 | $2.9M | 166k | 17.47 | |
| Atricure | 3.7 | $2.4M | 341k | 6.90 | |
| Protalix Biotherapeutics | 3.4 | $2.2M | 419k | 5.19 | |
| D Rigel Pharmaceutical S Inc Com Common Stock 7 | 3.2 | $2.0M | 311k | 6.50 | |
| Xenoport | 2.8 | $1.7M | 225k | 7.77 | |
| Cardionet | 2.2 | $1.4M | 606k | 2.28 | |
| Rti Biologics | 2.2 | $1.4M | 321k | 4.27 | |
| Mannkind Corp Note 3.7 50% 12/1 5 | 2.1 | $1.3M | 1.9M | 0.71 | |
| Dyax | 2.0 | $1.3M | 360k | 3.48 | |
| Cutera | 1.7 | $1.1M | 120k | 9.00 | |
| D Achillion Pharmaceuticals Inc. Common Stock 0 | 1.7 | $1.1M | 133k | 8.01 | |
| DISCOVERY Laboratories | 1.7 | $1.1M | 501k | 2.11 | |
| Trans1 | 1.5 | $931k | 375k | 2.48 | |
| Derma Sciences Inc Com par $.01 2 | 1.4 | $910k | 82k | 11.11 | |
| Nuvasive Inc Note 2. 750% 7/0 6 | 1.4 | $900k | 1.0M | 0.90 | |
| Nxstage Medical In | 1.4 | $892k | 79k | 11.25 | |
| Syneron Medical Ltd ord shs m | 1.4 | $884k | 102k | 8.67 | |
| Spectranetics | 1.4 | $877k | 59k | 14.77 | |
| SH BEN INT Infusystem Hldgs | 1.3 | $813k | 542k | 1.50 | |
| Biospecifics Tech | 1.2 | $773k | 52k | 14.95 | |
| Greatbatch | 1.2 | $777k | 33k | 23.23 | |
| Cardica | 1.1 | $698k | 635k | 1.10 | |
| Johnson & Johnson | 1.0 | $659k | 9.4k | 70.11 | |
| Exactech | 0.9 | $570k | 34k | 16.95 | |
| D Vertex Pharmaceutica Ls Inc Co Common Stock 9 | 0.8 | $515k | 12k | 41.87 | |
| Dendreon Corporation | 0.6 | $366k | 69k | 5.30 | |
| Masimo Corporation | 0.6 | $368k | 18k | 21.03 | |
| Stereotaxis Inc C ommon stock 8 | 0.6 | $362k | 142k | 2.55 | |
| Cardiovascular Systems | 0.6 | $357k | 29k | 12.54 | |
| Precision Optics | 0.5 | $331k | 389k | 0.85 | |
| Digirad | 0.5 | $306k | 149k | 2.05 | |
| Theragenics Corp | 0.5 | $289k | 182k | 1.59 | |
| Edap Tms Sa Spons ored adr 2 | 0.5 | $285k | 140k | 2.04 | |
| Vascular Solutions | 0.4 | $273k | 17k | 15.78 | |
| Lpath | 0.4 | $248k | 49k | 5.05 | |
| Graymark Healthcare Inc Com Pa r $.0001 3 | 0.2 | $159k | 693k | 0.23 | |
| Uroplasty | 0.2 | $162k | 50k | 3.25 | |
| Neurometrix | 0.1 | $85k | 199k | 0.43 | |
| Trovagene Inc *w Exp 9 9/99/999 8 | 0.1 | $81k | 31k | 2.59 | |
| Palatin Technologies Inc Com par $.01 6 | 0.1 | $78k | 130k | 0.60 | |
| Combimatrix Corp *w Exp 0 5/01/201 2 | 0.0 | $999.750000 | 2.3k | 0.43 |
